Literature DB >> 16547415

Phylogenetic analysis of envelope glycoprotein (E1) gene of rubella viruses prevalent in Japan in 2004.

Mika Saitoh1, Naomi Shinkawa, Shinichi Shimada, Yukari Segawa, Kenji Sadamasu, Michiya Hasegawa, Masahiko Kato, Kunihisa Kozawa, Tsuyoshi Kuramoto, Osamu Nishio, Hirokazu Kimura.   

Abstract

We performed a molecular epidemiological study on the envelope glycoprotein gene (E1 gene) obtained by PCR amplification from specimens of 17 rubella patients in certain areas (Gunma, Saitama, and Kagoshima prefectures, and Tokyo metropolitan area) in Japan in 2004. In these sequences of partially amplified DNAs (283 bases) within the E1 gene, no nucleotide substitution was observed. They were classified into genotype 1D of clade 1 in the constructed phylogenetic tree. One amino acid substitution was found between the amino acid sequence predicted from these DNAs and those of Japanese strains [To-336 vaccine strain (To-336 vac) and its wild progenitor (To-336 wt)]. The results suggest that the rubella viruses (RV) prevalent in certain areas of Japan in 2004 were highly homologous and were closely related with Japanese vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547415     DOI: 10.1111/j.1348-0421.2006.tb03784.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009.

Authors:  Christelle Vauloup-Fellous; Judith M Hübschen; Emily S Abernathy; Joseph Icenogle; Nicolas Gaidot; Pascal Dubreuil; Isabelle Parent-du-Châtelet; Liliane Grangeot-Keros; Claude P Muller
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

2.  Phylogenetic analysis of rubella virus strains from an outbreak in Madrid, Spain, from 2004 to 2005.

Authors:  A O Martínez-Torres; M M Mosquera; J C Sanz; B Ramos; J E Echevarría
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.